The Inflation Reduction Act (IRA) mandated that the federal government begin to negotiate prices for high-impact medications on behalf of its Medicare beneficiaries. On August 15, the Centers for Medicare and Medicaid Services (CMS) announced the negotiated prices for the first 10 medications on its target list. The discounted prices will go into effect in … Continue reading The IRA Price Negotiation Discussion for Enbrel® and Stelara® Biosimilars